thiorphan has been researched along with Cirrhosis, Liver in 1 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dussaule, JC | 1 |
Grangé, JD | 1 |
Wolf, JP | 1 |
Lecomte, JM | 1 |
Gros, C | 1 |
Schwartz, JC | 1 |
Bodin, F | 1 |
Ardaillou, R | 1 |
1 trial available for thiorphan and Cirrhosis, Liver
Article | Year |
---|---|
Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
Topics: Administration, Oral; Adult; Aldosterone; Atrial Natriuretic Factor; Cyclic GMP; Dose-Response Relat | 1991 |